Activation of factor IX by activated factor X: a link between the extrinsic and intrinsic coagulation systems  by Kalousek, Frantisek et al.
Volume 50, number 3 FEBS LETTERS I-cbruary 1975 
ACTIVATION OF FACTOR IX BY ACTIVATED FACTOR X: A LINK BETWEEN THE 
EXTRINSIC AND INTRINSIC COAGULATION SYSTEMS* 
Frantisek KALOUSEK, William KONIGSBERG and Yale NEMERSON 
Department of Molecular Biophysics and Biochemistry and the Department of Internal Medicine, 
Yale University School of Medicine, New Haven, Connecticut, 06510, USA 
Received 30 December 1974 
1 . Introduction 
Blood coagulation is initiated by two pathways 
which converge at a point where factor X is converted 
to factor Xa. In the intrinsic pathway, this reaction is 
catalyzed by activated factor IX; in the extrinsic, or 
tissue factor pathway, the conversion is catalyzed by a 
complex of tissue factor and factor VII [l-3] . Until 
recently, it had been thought that Xa acted only on 
prothrombin, but data from this laboratory have shown 
that factors X, X, and VII all have bonds which are 
cleaved by X, [4,5]. In view of the fact that X, acts 
on three homologous proteins, prothrombin and fac- 
tors VII and X [6], we studied its effect on a fourth 
homologous protein, factor IX. We now report that 
factor X, converts factor IX to an active form. By 
examining the reaction products by electrophoresis in 
acrylamide gels containing sodium dodecylsulfate, we 
conclude that activation of the zymogen is accompan- 
ied by cleavage of at least two peptide bonds. 
2. Materials and methods 
Prothrombin and factors VII, X and X, were pre- 
pared as previously described [4]. Factor IX was puri- 
fied from the descending limb of the prothrombin 
peak obtained by DEAE-Sephadex chromatography of 
a barium citrate eluate of bovine plasma [5]. Factor 
VII was removed from the mixture by affinity chroma- 
tography on benzamidine coupled to agarose [7]. 
Prothrombin was removed by chromatography on he- 
parin-agarose [8] ; factor IX was freed of residual con- 
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taminants by preparative acrylamide gel electrophore- 
sis as previously described [9]. The final preparation 
was purified about 20 000-fold, in good agreement 
with the reported value [8]. 
Factors IX and IX, were assayed as described by 
Fujikawa et al. [I 11, except that factor IX-deficient 
canine plasma was used as the substrate. 
Electrophoresis was performed in acrylamide gel 
slabs and stained for protein as previously described 
[4] . Gels were also stained for carbohydrate [IO] . 
3. Results 
Incubation of factor IX (3.0 mg/ml) with factor X, 
resulted in the rapid appearance of coagulant activity 
(fig.1). At the highest enzyme concentration used (a 
ratio of 1:20, w/w) maximum activity was obtained in 
30 min. Examination of the electrophoretic gel (flg.2) 
however, shows some factor IX to be present at this 
time suggesting that degradation is proceeding at about 
the same rate as is activation. In the absence of either 
calcium ions or phospholipids, no activation was 
observed (fig. 1). Thus, the same cofactors are required 
for the factor X,-catalyzed activation of factor IX as 
are required for X, to cleave the susceptible bonds in 
factor X and X, [4] and factor VII [S] . For activation 
of prothrombin, a plasma protein cofactor, factor V, 
is also required for optimal rates. 
As noted in fig.1, with lower enzyme concentrations 
the reaction did not go to completion as judged by bio- 
assay and by electrophoresis (not shown). Activated 
factor IX requires factor VIII, a non-enzymatic plasma 
protein, to accelerate the coagulation of plasma [ 11. 
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Fig.1. Time course of activation of factor IX by activated fac- 
tor X. The incubation contained 1 .S mg factor IX (estimated 
from the A 2 I o, assuming A ‘% = I O), 0.05 mg mixed brain 210 
phospholipids [4], 12 pmoles CaCl, and the indicated amount 
of X, in 0.5 ml 0.05 M Tris, 0.1 M NaCI, pH 7.4. After incu- 
bation at 37°C for the indicated intervals, aliquots were remov- 
ed, diluted in the same buffer containing 0.2% ovalbumin and 
assayed for activated factor IX. In the experiments in which 
CaCl, or phospholipids were omitted, the X, to IX ratio was 
1:20. 
Fig.2. Sodium dodecylsulfate polyacrylamide gel electrophoresis of the activation of factor IX by activated factor X. Conditions 
the same as for fig.1. Activation was accomplished with a 1:20 ratio of Xa to IX. Theouter channels contain molecular weight 
standards: phosphorylase, bovine serum albumin, ovalbumin, chymotrypsinogen and pancreatic ribonuclease. At 0, 3,5, 10, 15,20, 
30 and 60 min. 30 pg of protein were removed and added to an equal volume of 4% sodium dodecylsufate-5% 2-mercaptoethanol 
and heated in a boiling water bath for 3 min. The molecular weights estimated by comparing the mobility of the various bands to 
the standards are indicated on the figure. 
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Our product was shown to be factor IX, by substitut- 
ing factor VIII-deficient plasma for factor IX-deficient 
plasma in the assay. Under these conditions there was 
no shortening of the clotting time even when factor IX 
was fully activated. 
The formation of activity was accompanied by the 
appearance of several new bands on the gel (tig.2). A 
new band with an apparent mol. wt of 46 000 appears 
first. Subsequently, bands at mol. wt 32 000, 16 000 
and 12 000 are noted. When a similar gel was stained 
for carbohydrate, all bands except the one at 16 000 
were positive. The bands at mol. wt 32 000 and 
16 000 apparently correspond to the heavy and light 
chains of factor IX, reported by Fujikawa et al. [ 1 I] . 
The presence of carbohydrate may explain the differ- 
ent estimates of molecular weights. 
4. Discussion 
When blood clots spontaneously, factor IX is con- 
verted to an active form, factor IX,, by the action of 
activated factor XI [12]. Activated factor IX, in turn, 
catalyzes the conversion of factor X to X, [l] . In the 
tissue factor pathway, a complex of tissue factor and 
factor VII promotes this conversion [2,3]. In this paper 
we show that factor X, can activate factor IX; thus, 
we have established that the tissue factor pathway can 
activate the intrinsic system by activating factor X 
which, in turn, converts factor IX to IX,. A link 
between the intrinsic and extrinsic coagulation path- 
ways has been suggested [ 12,131, but the enzyme 
involved has not been previously identified. 
The amount of coagulant activity formed when fac- 
tor IX is incubated with activated factor X is a direct 
function of the concentration of factor X, (fig.1). 
This same phenomenon is observed when factor X is 
activated by the tissue factor-factor VII complex [5,7] 
and when prothrombin is activated by a complex of 
X,, factor V, calcium ions and phospholipids [ 151. In 
the former case, this damped activation has been ascribed 
to proteolytic inactivation of factor VII by X, [5,7]. 
In the latter, inactivation of the non-proteolytic cofac- 
tor, factor V, limits prothrombin activation [ 151. The 
mechanism of the damping of the X,-catalyzed activa- 
tion of factor IX is not known, but may involve the 
inactivation of X, by activated factor IX. 
Fujikawa et al. [ 1 l] investigated the mechanism of 
activation of factor IX by factor XI,, and proposed 
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that the first event is a cleavage of one peptide bond 
converting a single chain zymogen into a two chain 
intermediate. A subsequent cleavage releases an activa- 
tion peptide yielding the active enzyme. The data we 
present suggest the same activation mechanism per- 
tains when the reaction is catalyzed by activated factor 
X. Chemical confirmation of the identity of the cleav- 
age sites awaits further study. 
In view of the fact that patients with a deficiency 
of factor XI have only a mild hemorrhagic disorder, an 
alternative mechanism for the activation of factor IX 
has often been suggested. With the identification of 
factor X, as an enzyme which can convert factor IX to 
IX,, we propose that the tissue factor pathway can 
generate sufficient activated factor X to activate fac- 
tor IX, by-passing factors XII and XI. Owing to the 
fact that factor XI-deficient patients do have a hemor-. 
rhagic tendency, we surmise that this alternate activa- 
tion of factor IX is less efficient than activation catalyz. 
ed by factor XI,. Indeed, comparing the data present- 
ed by Fujikawa et al. [ 1 l] to those presented in fig.1 
of this paper, it appears that activated factor X catalyz- 
es the conversion of factor IX at about 20% the rate 
obtained with activated factor XI. 
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